Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Uracil × Clear all

NCT00464919 2009-07-07

Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular